0001735276-21-000078.txt : 20210809
0001735276-21-000078.hdr.sgml : 20210809
20210809160949
ACCESSION NUMBER: 0001735276-21-000078
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210806
FILED AS OF DATE: 20210809
DATE AS OF CHANGE: 20210809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenstreet Yvonne
CENTRAL INDEX KEY: 0001446125
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36407
FILM NUMBER: 211156544
MAIL ADDRESS:
STREET 1: PACIRA PHARMACEUTICALS, INC.
STREET 2: 5 SYLVAN WAY
CITY: PARSIPPANY
STATE: NJ
ZIP: 07054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001178670
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770602661
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 675 WEST KENDALL STREET
STREET 2: HENRI A. TERMEER SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 551-8200
MAIL ADDRESS:
STREET 1: 675 WEST KENDALL STREET
STREET 2: HENRI A. TERMEER SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020724
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-08-06
0
0001178670
ALNYLAM PHARMACEUTICALS, INC.
ALNY
0001446125
Greenstreet Yvonne
675 WEST KENDALL STREET
HENRI A. TERMEER SQUARE
CAMBRIDGE
MA
02142
0
1
0
0
President & COO
Common Stock
2021-08-06
4
M
0
28064
77.1
A
39087
D
Common Stock
2021-08-06
4
M
0
25000
77.1
A
64087
D
Common Stock
2021-08-06
4
S
0
53064
199.0
D
11023
D
Common Stock
407
I
by Managed Account
Performance Stock Option 2016 (right to buy)
77.1
2021-08-06
4
M
0
25000
0.0
D
2018-08-13
2026-09-18
Common Stock
25000
0
D
Stock Option (right to buy)
77.1
2021-08-06
4
M
0
28064
0.0
D
2026-09-18
Common Stock
28064
0
D
All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2021.
Reflects shares of ALNY common stock acquired by the reporting person under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
The stock option vested as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
By: /s/ Mary Beth DeLena, Attorney-in-Fact For: Yvonne Greenstreet
2021-08-09